165 related articles for article (PubMed ID: 6986497)
1. Cellular cytotoxicity and serum inhibition in normal mice following transfer of syngeneic tumor-sensitized cells.
Fisher B; Wolmark N; Saffer EA
J Natl Cancer Inst; 1980 Mar; 64(3):579-85. PubMed ID: 6986497
[TBL] [Abstract][Full Text] [Related]
2. Cellular cytotoxicity in tumor-bearing mice after transfer of normal or tumor-sensitized lymphoid cells.
Fisher B; Wolmark N; Saffer EA
J Natl Cancer Inst; 1980 Dec; 65(6):1303-5. PubMed ID: 6933275
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific immune responsiveness of the tumor-bearing host.
Burk MW; Yu S; McKhann CF
Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
[TBL] [Abstract][Full Text] [Related]
4. Cellular cytotoxicity and serum inhibition in normal mice following transfer of xenogeneic tumor-sensitized cells.
Fisher B; Wolmark N; Saffer EA
Cancer Res; 1979 Dec; 39(12):4772-6. PubMed ID: 498106
[No Abstract] [Full Text] [Related]
5. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
Lee FH; Currie D; Hwang KM
Cancer Res; 1984 Dec; 44(12 Pt 1):5491-8. PubMed ID: 6208997
[TBL] [Abstract][Full Text] [Related]
6. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
Fidler IJ; Kataoka T; Hanna MG
Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
[TBL] [Abstract][Full Text] [Related]
7. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
Bernstein ID
J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
[TBL] [Abstract][Full Text] [Related]
8. In vitro stimulation and inhibition of tumor cell growth mediated by different lymphoid cell populations.
Norbury KC
Cancer Res; 1977 May; 37(5):1408-15. PubMed ID: 66982
[TBL] [Abstract][Full Text] [Related]
9. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
[TBL] [Abstract][Full Text] [Related]
10. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
Fujii T; Igarashi T; Kishimoto S
J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
[TBL] [Abstract][Full Text] [Related]
11. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. II. Enhancement of in vitro cell-mediated cytotoxicity by combined chemotherapy-immunotherapy.
Adler A; Keisari Y; Ofir R
J Natl Cancer Inst; 1985 Feb; 74(2):429-36. PubMed ID: 3856051
[TBL] [Abstract][Full Text] [Related]
12. In vivo generation of tumor-specific cytotoxic T-cells in the regional lymph node: effect of subcutaneous inoculation of mls-disparate spleen cells around implanted tumors in mice.
Higasa M; Yamada K; Takagaki Y; Aoki M; Shinka S; Dohi Y
Cancer Res; 1986 Oct; 46(10):4991-4. PubMed ID: 3489518
[TBL] [Abstract][Full Text] [Related]
13. Tumor specificity, serum inhibition, and influence of regional lymph nodes on cytotoxic macrophages from cultured bone marrow.
Fisher B; Hanlon JT; Linta J; Saffer E
Cancer Res; 1977 Oct; 37(10):3628-33. PubMed ID: 908011
[No Abstract] [Full Text] [Related]
14. Distribution of normal T lymphocytes in tumor-bearing rats.
Klobusická M; Koníková E
Neoplasma; 1982; 29(6):727-34. PubMed ID: 6984490
[TBL] [Abstract][Full Text] [Related]
15. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
Bristol JA; Schlom J; Abrams SI
Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
[TBL] [Abstract][Full Text] [Related]
16. Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo.
Hanna N; Burton RC
J Immunol; 1981 Nov; 127(5):1754-8. PubMed ID: 7299115
[TBL] [Abstract][Full Text] [Related]
17. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
18. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
Wang J; Saffold S; Cao X; Krauss J; Chen W
J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
[TBL] [Abstract][Full Text] [Related]
19. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
Ruppert B; Blazar B; Medina D; Heppner G
J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122
[TBL] [Abstract][Full Text] [Related]
20. Effect of polyethylene glycol 6000 on the generation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells cultured in the presence or absence of inactivated stimulator tumor cells.
Przepiorka D; Mokyr MB; Dray S
Cancer Res; 1980 Dec; 40(12):4565-70. PubMed ID: 7438090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
